2025 Subject Index
Published in Volume 26, Issue 6 (2025)
#
A
- Acute respiratory failure, 32, 374
- adolescents, 290
- adverse effects, 340
- air pollutants, 314
- Air pollution, 197, 264, 333
- airway inflammation, 34
- allergic diseases, 34
- and lung cancer', 155
- annual data, 238
- anxiety, 132, 231
- artificial intelligence, 107
- aspirin, 77
- asthma, 77, 264
- asymmetrical cannula, 374
- attitude, 224
- Awareness, 260
B
C
- cancer, 28, 55
- Capsaicin, 97
- cardiac arrest, 43
- Cardiac autonomic function, 349
- Catastrophizing, 17
- Cell culture, 23
- cell migration, 4, 21
- ChatGPT, 366
- chest CT, 107
- chest diseases, 366
- chest X-ray, 266
- chitotriosidase, 217
- chronic cough, 97
- chronic obstructive pulmonary disease, 17, 32, 349
- chronic respiratory failure, 25
- Cigarette smoking, 69
- circRNA, 25
- clinical course, 217
- complications, 340
- continuous positive airway pressure, 32
- COPD, 115, 262, 264
- COVID-19, 85, 107, 125, 132, 137, 213
- Cystic fibrosis, 115, 238, 248
- Cystic Fibrosis Registry of Türkiye, 238
D
E
- e-cigarette, 40
- e-vapers, 40
- Earthquake, 231
- education, 208
- electroencephalography, 145
- electromyography, 145
- Electronic cigarette, 290
- elexacaftor, 248
- endobronchial ultrasound-guided transbronchial needle aspiration, 183
- Environmental exposure, 1
- Environmental exposures, 7
- environmental health, 264
- epidemiology, 176
- Epithelial-mesenchymal transition, 4
- ethics, 366
- ethnicity, 152
- exercise capacity, 323
- exhaled breath condensate, 15
- exosomes, 28, 34
- Exposome, 4, 264
- extracellular matrix, 10
F
G
H
I
- ICU, 85
- Idiopathic pulmonary fibrosis, 272
- immunomodulatory therapy, 34
- impulse oscillometry, 333
- in vitro models, 7
- incidence, 155
- infection, 23, 25
- inflammation, 125, 231
- inflammatory markers, 333
- insomnia, 9, 211, 213
- inspiratory flow, 282
- inspiratory pressure, 282
- inspiratory volume, 282
- interferon-gamma release tests, 176
- interstitial lung disease, 115, 208
- Interstitial lung diseases, 215
- interventional pulmonology, 359
- Inverted gray-scale, 266
- iPSCs-derived models, 1
- ivacaftor, 248
K
L
- Language models, 366
- large-scale production, 28
- Latent tuberculosis infection, 176
- LC-MS/MS, 18
- lead poisoning, 40
- long Coronavirus disease-2019, 211
- Long-Coronavirus disease, 87
- long-term home mechanical ventilation, 25
- long-term outcomes, 272, 323
- Lung cancer, 4, 21, 23, 25, 32, 183
- lung diseases, 264
- lung function, 272, 307
- lung tumor-stroma interface, 10
M
- maximum expiratory pressure, 153
- maximum inspiratory pressure, 153
- mechanobiology, 4
- mediastinal diseases, 183
- medical student, 48
- medicine, 366
- Mesenchymal stem cell, 34
- metabolomics, 15, 18
- methacholine chloride, 97
- microplastics, 7
- mortality, 87
- mortality myocardial infarction, 43
- Muscle endurance test, 282
- Myocardial infarction, 307
N
- NAMs, 4
- Nano-delivery systems, 31
- nanoparticles, 31
- nanotechnology in oncology, 28
- nasal polyp, 77
- Needle trap devices, 12
- neuromuscular disorders, 25
- next generation sequencing, 191
- nintedanib, 272
- Non-contrast computed tomography, 298
- Non-invasive mechanical ventilation, 32
- non-invasive positive pressure ventilation, 32
- Non-invasive ventilation, 25, 340
- non-steroidal anti-inflammatory drug hypersensitivity, 77
- Non-steroidal anti-inflammatory drug-exacerbated respiratory disease, 77
- nurses, 224
O
P
- palliative use of non-invasive ventilation, 32
- particulate matter, 197, 333
- pathophysiology, 97
- patient, 55
- patient perspective, 208
- patient-based learning, 208
- perioperative care, 183
- Phe508del, 248
- pirfenidone, 272
- PM2.5, 264
- pneumonia, 262
- positive airway pressure, 132
- positive end-expiratory pressure, 374
- Post-pulmonary tuberculosis, 323
- Postinfectious bronchiolitis obliterans, 191
- precision prevention, 264
- premature death, 197
- prevention, 264
- principal component analysis, 15
- pulmonary artery, 298
- pulmonary fibrosis, 7, 125
- Pulmonary function testing, 137
- pulmonary nodule, 266
- pulmonary rehabilitation, 323
- pulmonary thromboembolism, 298
- pulmonary vascular diseases, 115
Q
R
- rare ILD, 208
- readmission, 87
- readmit, 85
- real-life data, 272
- reliability, 17, 290
- resistance training, 349
- Respiratory diseases, 31, 314
- respiratory health, 323
- respiratory infections, 262
- respiratory intensive care, 115
- respiratory mechanics, 282
- respiratory muscle, 152
- respiratory muscle strength, 307
- respiratory muscles, 145, 282
- rheumatic disease, 176
S
- safety, 248
- saliva, 18
- sample preparation, 12
- Sarcoidosis, 217
- scale, 290
- serum starvation, 21
- silica dust, 7
- sleep disorder, 132
- sleep disorders, 213
- sleep-disordered breathing, 43
- smoke-free law, 48
- smoke-free policy, 69
- Smoking cessation, 224
- socio-demographic index, 155
- socio-economic status, 197
- software tool, 197
- spirometry, 333
- standard image, 266
- Staphylococcus aureus, 23, 25
- stigmatization, 88
- stroke, 43
- students, 69
- Symdeko, 248
- systematic review, 248
T
- targeted-specific synthetic disease-modifying antirheumatic drugs, 176
- Telemedicine, 208
- tezacaftor, 248
- thin-film microextraction, 18
- third-hand smoke, 55
- THP-1 cells, 28
- tissue engineering, 10
- Tobacco consumption, 48
- tobacco control, 69
- Tobacco use, 61
- tobacco-free, 1
- tolerance, 340
- Trikafta, 248
- Tuberculosis, 88
U
- university tobacco policies, 69
V
W
- whole exon study, 191


